CSI Market
Sign In | Register

Vyant Bio Inc (VYNT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VYNT Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Vyant Bio Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
12 Months 		(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Operating Activities
Income-22.69
Depreciation & amortization0.52
Amortization of Other Assets0.00
Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.42
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation1.19
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Gain Loss On Derivative Instruments Net Pretax-
Gains Losses On Restructuring Of Debt-
Share Based Compensation Research And Development-
Share Based Compensation Consulting-
Noncash Or Part Noncash Acquisition Fixed Assets Acquired-
Business Combination Contingent Consideration Arrangements Changein Amount of Warrant Liability and Acquisition Note Payable Liability-
Increase Decrease Deferred Rent Expense-
Warrants and Rights Reclassified-
Disposal Group Including Discontinued Operation Property Plant And Equipment-
Disposal Group Including Discontinued Operation Goodwill-
Disposal Group Including Discontinued Operation Other Noncurrent Assets-
Operating Lease Right Of Use Asset Amortization Expense0.25
Change In Fair Value Of Sharesettlement Obligation Derivative-
Change In Fair Value Of Convertible Note With Fair Value Election-
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings-
Increase Decrease In Operating Lease Liability-0.19
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Other Receivables0.11
Increase (Decrease) in Accounts Payable, Trade-0.09
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.32
Other Working Capital0.39
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations6.09
Net Cash flow from Operating Activities-13.68
Investing Activities
Capital Expenditures-0.62
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Deferred Initial Public Offering Costs Funded Through Accounts Payable And Accrued Expenses-
Debt Instrument Unamortized Discount-
Noncash Or Part Noncash Divestiture Amount Of Consideration Received-
Offering Costs Discounted-
Paymentsto Acquire Businesses Escrow Deposit-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations3.88
Net Cash Flow from Investing Activities3.26
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-0.19
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-20.64
Finance Lease Principal Payments-
Payment of Fractional Share Settlement-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations20.61
Proceeds From Lease Financing0.27
Proceeds From Repayments Of Long Term Debt And Capitasl Securities-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.15
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-14.30
Total Cash Flow-10.57
4 historic quarters locked

Sign in to unlock the full Vyant Bio Inc cash flow history.

Sign In Create Free Account

About Vyant Bio Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-23-010255

Figures are derived from filed reports and may be restated. Historical data is subject to revision.